Rise Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53.2K | Buy |
101
+4
| +4% | +$2.11K | 0.02% | 226 |
|
|
2025
Q1 | $61.6K | Buy |
97
+10
| +11% | +$6.35K | 0.03% | 201 |
|
|
2024
Q4 | $62K | Buy |
87
+1
| +1% | +$712 | 0.03% | 194 |
|
|
2024
Q3 | $90.4K | Hold |
86
| – | – | 0.04% | 158 |
|
|
2024
Q2 | $90.4K | Hold |
86
| – | – | 0.05% | 158 |
|
|
2024
Q1 | $82.8K | Buy |
86
+61
| +244% | +$58.7K | 0.04% | 166 |
|
|
2023
Q4 | $22K | Hold |
25
| – | – | 0.02% | 245 |
|
|
2023
Q3 | $20.6K | Hold |
25
| – | – | 0.02% | 229 |
|
|
2023
Q2 | $18K | Hold |
25
| – | – | 0.01% | 250 |
|
|
2023
Q1 | $20.5K | Hold |
25
| – | – | 0.02% | 250 |
|
|
2022
Q4 | $18K | Hold |
25
| – | – | 0.01% | 260 |
|
|
2022
Q3 | $17K | Hold |
25
| – | – | 0.01% | 268 |
|
|
2022
Q2 | $15K | Hold |
25
| – | – | 0.02% | 274 |
|
|
2022
Q1 | $17K | Hold |
25
| – | – | 0.02% | 266 |
|
|
2021
Q4 | $15.8K | Buy |
+25
| New | +$15.8K | 0.02% | 273 |
|